|
| Press Releases |
|
|
| Wednesday, January 21, 2026 |
|
|
Dowway Proposes Rebranding with a New Name 'Defeng Solife' |
| Dowway Holdings Limited ("Dowway" or the "Group"; Stock Code: 8403), a leading integrated exhibition and event management service provider in China, is pleased to announce that it plans to change its Chinese name, its English name from "Dowway Holdings Limited" to "Defeng Solife Holdings Limited' ('Defeng Solife'). more info >> |
|
|
天平道合擬煥新改名為「德豐宿來」 |
| 中國領先的綜合展覽及活動管理服務供應商天平道合控股有限公司（「天平道合」或「集團」；股份代號：8403）欣然宣布，集團計劃將中文名稱由「天平道合控股有限公司」更名為「德豐宿來控股有限公司」，英文名稱由「Dowway Holdings Limited」更名為「Defeng Solife Holdings Limited」（「德豐宿來」），以彰顯集團未來在整合展覽活動策劃、消費產品銷售及數字平台服務的同時，進一步深化在文化展覽、沉浸式體驗項目等領域的佈局，提升集團品牌競爭力，開啟高質量發展的新篇章。 more info >> |
|
|
天平道合拟焕新改名为"德丰宿来" |
| 中国领先的综合展览及活动管理服务供货商天平道合控股有限公司（"天平道合"或"集团"；股份代号：8403）欣然宣布，集团计划将中文名称由 "天平道合控股有限公司"更名为"德丰宿来控股有限公司"，英文名称由"Dowway Holdings Limited"更名为"Defeng Solife Holdings Limited"（"德丰宿来"），以彰显集团未来在整合展览活动策划、消费产品销售及数字平台服务的同时，进一步深化在文化展览、沉浸式体验项目等领域的布局，提升集团品牌竞争力，开启高质量发展的新篇章。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
維昇藥業（2561.HK）維臻高(R)獲批：重長效生長激素王者登場 重構百億市場的商業天花板
Feb 25, 2026 14:58 HKT/SGT
|
|
|
Hong Kong Tech Delegation Heading for Market Expansion at Mobile World Congress 2026
Feb 25, 2026 14:54 HKT/SGT
|
|
|
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
Feb 25, 2026 12:46 HKT/SGT
|
|
|
Shoucheng Holdings (00697.HK) Sees Long-Term International Capital Rotation as Robotics Portfolio Enters Harvest Phase
Feb 25, 2026 12:23 HKT/SGT
|
|
|
首程控股（00697.HK）迎來國際長線接盤 機器人產業生態進入價值收割期
Feb 25, 2026 12:23 HKT/SGT
|
|
|
首程控股（00697.HK）迎来国际长线接盘 机器人产业生态进入价值收割期
Feb 25, 2026 12:23 HKT/SGT
|
|
|
ベイシアのスーパーマーケット内の冷蔵・冷凍庫の温度点検・記録業務を富士通のIoT可視化ソリューションにより自動化
Feb 25, 2026 12:00: JST
|
|
|
Beisia Automates Supermarket Refrigerator Temperature Monitoring and Recording with Fujitsu's IoT Visualization Solution
Feb 25, 2026 12:00 JST
|
|
|
國泰君安國際獲批使用SIMM 衍生品風險管理接軌國際標準
Feb 25, 2026 10:34 HKT/SGT
|
|
|
国泰君安国际获批使用SIMM 衍生品风险管理接轨国际标准
Feb 25, 2026 10:34 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 22:30: JST
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT/SGT
|
|
|
TANAKA to Provide Medals for the Tokyo Marathon 2026 That Represent All the Participants in the Event with Woven Lines
Feb 24, 2026 22:00 JST
|
|
|
康哲藥業（867.HK/8A8.SG）：創新藥磷酸蘆可替尼乳膏增加特應性皮炎（AD）適應症中國上市許可申請獲受理並獲納入優先審評
Feb 24, 2026 20:31 HKT/SGT
|
|
|
康哲药业（867.HK/8A8.SG）：创新药磷酸芦可替尼乳膏增加特应性皮炎（AD）适应症中国上市许可申请获受理并获纳入优先审评
Feb 24, 2026 20:19 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
